feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",https://benzinga.com/general/biotech/21/05/21009633/the-daily-biotech-pulse-split-verdict-for-chemocentryx-nkarta-crispr-in-cell-therapy-collaboratio,https://j.mp/3tm81B2
